Welcome to the Brown & Crouppen Crestor page. Brown & Crouppen has thrived for over a quarter of a century because of our shared commitment to deliver the best possible service to clients throughout the United States. We have represented many people injured by unsafe drugs and medical devices. Our attorneys have worked hard to ensure that negligent manufacturers and suppliers are held accountable for the injuries and fatalities caused by their unsafe products. With the support of some of the nation’s premier drug litigation specialists, Brown & Crouppen has tackled some of the more well known prescription cases including Rezulin™, Fen-Phen™, Lotronex™, OxyContin™, Prempro™, Baycol™, PPA™, and Zyprexa™. We are also representing clients who have been injured by Crestor (rosuvastatin).

Crestor is manufactured by Astra-Zeneca Pharmaceuticals, and is a member of the powerful “statin” family of drugs used to treat high-cholesterol. Patients with under active thyroids or kidney problems are at increased risk for rhabdomolysis when they take Crestor. Rhabdomolysis is a breakdown of muscle fibers that frequently results in kidney damage and can be fatal. Controversy continues to swirl around Crestor, which was approved by the Food & Drug Administration (FDA) in August of 2003. Less than a year later, the FDA has issued a Public Health Advisory regarding the drug. If you or someone you love has been injured or has died because of the adverse effects of rosuvastatin, you may be entitled to receive compensation. The Brown & Crouppen team has helped thousands of clients receive over 200 million dollars in settlements and awards for damages in personal injury cases. We may be able to help you.

Crestor is one of six cholesterol lowering “statin” medications approved by the FDA. Another statin drug, cerivastatin (Baycol), has already been removed from the market because of reports of rhabdomyolysis and fatalities. The same potential for kidney toxicity has been linked to the use of Crestor. AstraZeneca’s has discontinued production of its 80 milligram strength dose and placed special restrictions on distribution of the 40 milligram dosage. Research has indicated that Crestor is the only remaining medication in the statin family to cause elevated urine protein, a potential warning sign of serious kidney problems.

AstraZeneneca PLC is the U.K.’s second-largest pharmaceutical producer. Their U.S. headquarters is in Fairfax, Virginia. It is disturbing to note that AstraZeneneca had delayed their application for FDA approval and halted clinical trials worldwide due to reports of kidney damage and muscle weakness. In June of this year, the London-based company issued a revised package insert for Crestor in Europe. Letters advise physicians to start patients on the lowest possible dose of the drug and prescriptions for the highest dose have been moved to the “specialist supervision” category. The letters also advise that prescriptions are prohibited in cases where patients are at high risk for rhabdomyolysis. U.S. Crestor labels already contain appropriate warnings; however in their June 9, 2004 health advisory, the FDA reinforces concern regarding the European label changes.

At Brown & Crouppen, we recognize the tactics that powerful drug makers use to market their products and avoid responsibility for the suffering they cause. We believe that the problems with rosuvastatin will continue, that people will continue to be injured and some will even die, while the drug makers will continue to profit. It is time to hold the manufacturers and suppliers of dangerous drugs accountable for their promises made and broken. If you or someone you love is taking Crestor, we urge you to contact your doctor for health advice. Our next recommendation is to consult with a qualified attorney who has expertise in personal injury and product liability claims. Call Brown & Crouppen. We have the experience, resources and talent to take on the big drug companies.

At Brown & Crouppen our experienced team of defective drug lawyers provide tough, aggressive representation for Crestor victims and their families. When you choose us to handle your lawsuit, our entire team becomes fully committed to your cause. We’ll find answers, hold negligent companies responsible and get you the compensation you deserve.

Brown & Crouppen can help you make informed decisions about your legal rights, so please call Brown & Crouppen at 1-800-536-HELP for your free legal consultation or save time with our online Contact Form.